This invited oral talk will consist of two parts. The first will summarize long-standing efforts to develop texaphyrin conjugates as targeted anticancer agents; the second will present newer work focused on the use of redox active gold carbenes as so-called immunogenic cell death agents.

Progress on Texas-inspired metal-based drug discovery and development efforts

Fall 2022 abstracts, posters, and presentations will launch in mid-September.

ACS Fall 2022

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.